Bengaluru-based dermatology-led skincare startup CHOSEN has raised $5 million in a Series A funding round. Fireside Ventures led the round, with participation from BOLD, Alkemi Growth Capital, and several angel investors. Notable backers include Avnish Anand and a group of practising dermatologists.
These dermatologists include Dr Chandan Asokan, Dr KC Nischal, Dr Punit Saraogi, Dr Nishita Ranka, and Dr Mikki Singh. CHOSEN’s clinical foundation continues to attract investor interest in India’s skincare market.
Science-led skincare for Indian consumers
Cosmetic dermatologist Dr Renita Rajan founded the company in 2020. The startup focuses on science-led skincare tailored for melanin-rich Indian skin. It builds products using insights from the exposome and genetic factors influencing skin health.
The company operates a clinic-to-consumer model combining dermatology expertise with direct distribution. The firm offers topical formulations and nutraceutical products addressing key skin concerns. These include pigmentation, skin texture, contour, and hair ageing. Its flagship products include SAFESCREEN NEXGEN sunscreen and the Sculpt contour system.
Also read: CHOSEN by Dermatology marks 6 years at Sixer Conclave
Capital to accelerate research and product development
The company plans to use the new capital to strengthen research and development capabilities. It will also expand its pipeline of clinically validated products.
CHOSEN aims to scale its dermatologist-led Centre of Excellence. The startup will also invest in talent across key business functions.
Founder and investors highlight clinical approach
Dr Renita Rajan said the funding validates the company’s science-led approach to skincare. She emphasised the need to build products suited for Indian environmental and genetic conditions. Investors highlighted the company’s clinical rigour and strong consumer adoption.
Fireside Ventures noted the brand’s trust-driven go-to-market strategy as a key differentiator. BOLD, L’Oréal’s investment arm, sees long-term potential in the dermocosmetics segment. Alkemi Growth Capital also backed the startup’s dermatologist-first positioning.
Growing demand for clinically backed skincare
India’s dermocosmetics market continues to grow as consumers demand clinically backed solutions. This trend has increased investor interest in specialised skincare brands. CHOSEN aims to bridge the gap between pharmaceutical dermatology and consumer skincare products.
The company positions itself as a science-first brand built for Indian skin needs. With fresh capital, CHOSEN plans to accelerate innovation and expand its clinical ecosystem. The startup also aims to scale its presence in India’s evolving skincare market.